MedicalSystem Biotechnology Co., Ltd. – FDA 483, Mar 14, 2019
An FDA inspection of MedicalSystem Biotechnology Co., Ltd., a medical device manufacturer in Ningbo, China, identified deficiencies in its complaint handling system. The firm's Customer Feedback Control Procedure was found to be incomplete, failing to ensure uniform and timely processing of complaints, proper documentation of oral complaints, and adequate evaluation for Medical Device Reporting. This indicates a significant issue with the firm's quality system regarding post-market surveillance and complaint management.
ID · bb2f8d5a-9318-452a-9efe-b322077968a2
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.